Share this Page:
A recent study presented by the Australia and New Zealand Urogenital and Prostate Cancer Clinical Trials Group has shown that health-related quality of life and management of cancer symptoms were significantly improved for metastatic kidney cancer patients who took a 12-week remote exercise programme.
The study assessed patients with metastatic kidney cancer who were on immunotherapy, either alone or in combination with other medications.
Patients were assessed via WhatsApp and were given exercise regimens of 3 to 5 hours per week for 4 to 6 days, which included both resistance and aerobic exercises.
Quality of life and symptom management were assessed before the start of the exercise programme and again after 12 weeks.
At 12 weeks, health-related quality of life scores were higher than before the exercise programme started. Additionally, the impact of symptoms such as fatigue, anxiety, sleep quality, depression, or pain was less at 12 weeks.
In conclusion, this study found that with supportive care, such as exercise, there were significant improvements in physical function and depressive symptoms in patient quality of life.
